Exome Asset Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-76,379	Closed	-$3.09M	–	54
2025 Q1	$3.09M	Buy	76,379 +7,771	+11%	+$315K	2.75%	12
2024 Q4	$1.91M	Sell	68,608 -8,492	-11%	-$236K	1.43%	30
2024 Q3	$2.21M	Buy	+77,100	New	+$2.21M	1.5%	30